Cargando…
Back to the future: DCB use instead of DES for the treatment of complex, native coronary artery disease
The increasing complexity of coronary artery lesions in patients with significant co-morbidities and the need for revascularization, but with the ineligibility for surgical approach, has turned the percutaneous coronary intervention a challenging task, especially in a setting in which short- and lon...
Autores principales: | Cortese, Bernardo, Sanchez-Jimenez, Erick |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8503473/ https://www.ncbi.nlm.nih.gov/pubmed/34650357 http://dx.doi.org/10.1093/eurheartj/suab091 |
Ejemplares similares
-
Impact of Scoring Balloon Angioplasty on Lesion Preparation for DCB Treatment of Coronary Lesions
por: Shin, Eun-Seok, et al.
Publicado: (2023) -
Adaptive Mechanisms of Shewanella xiamenensis DCB 2-1 Metallophilicity
por: Abuladze, Marina, et al.
Publicado: (2023) -
Long-term safety of paclitaxel drug-coated balloon-only angioplasty for de novo coronary artery disease: the SPARTAN DCB study
por: Merinopoulos, Ioannis, et al.
Publicado: (2020) -
Response to pre-dilatation with POBA can predict target lesion revascularization after DCB angioplasty for de novo small coronary artery lesions
por: Takamura, Taka-aki, et al.
Publicado: (2022) -
A Study on the Susceptibility to SCC of 7050 Aluminum Alloy by DCB Specimens
por: Qi, Xing, et al.
Publicado: (2016)